BiotechTube
Home/Aqilion/Sarah Fredriksson
SF

Sarah Fredriksson

CEO

Aqilion

Therapeutic Areas

Chronic Inflammatory DiseasesAutoimmune Diseases

Aqilion Pipeline

DrugIndicationPhase
AQ280Eosinophilic Esophagitis (EoE)Phase 1/Preclinical
AQ128Inflammatory Disease (unspecified)Preclinical